OPKO Health, Inc. (OPK) — Financial statements
Income statement, balance sheet, and cash flow for OPKO Health, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 607↓14.9% | 713↓17.4% | 863↓14.0% | 1,004↓43.4% | 1,775 | |
| Cost of Revenue | 479↑19.1% | 402↓26.3% | 545↓23.8% | 716↓40.0% | 1,193 | |
| Gross Profit | 128↓58.8% | 311↓2.2% | 318↑10.4% | 288↓50.4% | 582 | |
| Operating Expenses | ||||||
| R&D Expenses | 124↑17.9% | 105↑17.4% | 90↑21.3% | 74↓3.9% | 77 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 223↓26.7% | 304↑1.2% | 301↓19.4% | 373↓20.5% | 469 | |
| Other Expenses | 0.00↓100.0% | 54↓36.9% | 85↑25.2% | 68↑297.9% | 17 | |
| Operating Expenses | 347↓25.1% | 463↓2.5% | 475↓7.6% | 514↓8.6% | 563 | |
| Total Costs & Expenses | 826↓4.5% | 865↓15.2% | 1,021↓17.1% | 1,230↓29.9% | 1,756 | |
| Operating Results | ||||||
| Operating Income | -219↓44.0% | -152↑3.2% | -157↑30.6% | -226↓1306.7% | 19 | |
| Depreciation & Amortization | 92↓6.7% | 98↓6.8% | 105↓3.1% | 109↑38.0% | 79 | |
| EBITDA | -127↓194.1% | 135↑306.5% | -66↑75.8% | -271↓424.0% | 84 | |
| EBIT | -219↓690.2% | 37↑121.7% | -171↑55.0% | -379↓7916.0% | 5 | |
| Interest & Other Income | ||||||
| Net Interest Income | -94↓139.9% | -39↓309.9% | -10↑5.5% | -10↑46.6% | -19 | |
| Interest Income | 15↑75.8% | 8↑111.5% | 4↑101.1% | 2↑6975.0% | 0.03 | |
| Interest Expense | 108↑128.5% | 47↑251.4% | 14↑12.0% | 12↓36.1% | 19 | |
| Non-Operating Income | 0.00↑100.0% | -189↓1471.6% | 14↓91.0% | 153↑1002.6% | 14 | |
| Other Income / Expenses | -22↓115.8% | 142↑617.1% | -27↑83.5% | -166↓395.9% | -33 | |
| Income Before Tax | -241↓2229.6% | -10↑94.4% | -184↑52.9% | -392↓2574.4% | -15 | |
| Income Tax Expense | -16↓136.7% | 43↑865.6% | 4↑107.0% | -63↓510.0% | 15 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -226↓324.2% | -53↑71.8% | -189↑42.5% | -328↓989.5% | -30 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -226↓324.0% | -53↑71.8% | -189↑42.5% | -328↓989.5% | -30 | |
| Bottom-Line Net Income | -226↓324.0% | -53↑71.8% | -189↑42.5% | -328↓989.5% | -30 | |
| EPS (Basic) | -0.30↓291.1% | -0.08↑69.3% | -0.25↑45.7% | -0.46↓911.0% | -0.05 | |
| EPS (Diluted) | -0.30↓291.1% | -0.08↑69.3% | -0.25↑45.7% | -0.46↓911.0% | -0.05 | |
| Weighted Average Shares | 751↑8.2% | 694↓7.7% | 752↑4.5% | 719↑11.0% | 648 | |
| Weighted Average Diluted Shares | 751↑8.2% | 694↓7.7% | 752↑4.5% | 719↑11.0% | 648 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.